Trials / Completed
CompletedNCT00152022
Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.
A Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 412 (planned)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and effectiveness of SPD465 compared to placebo (a capsule with no medication in it) in the treatment of ADHD. The study will also look at how SPD465 affects the participants sleep and how they perceive their quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulphate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate. |
Timeline
- Start date
- 2005-04-25
- Primary completion
- 2005-11-04
- Completion
- 2005-11-04
- First posted
- 2005-09-09
- Last updated
- 2021-07-13
Source: ClinicalTrials.gov record NCT00152022. Inclusion in this directory is not an endorsement.